Ascendis Pharma (ASND) PT Raised to $230 at RBC Capital
Tweet Send to a Friend
(Updated - August 8, 2025 8:40 AM EDT)
RBC Capital analyst Luca Issi raised the price target on Ascendis ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
RBC Capital analyst Luca Issi raised the price target on Ascendis ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
